| Q39181108 | AML1/ETO sensitizes via TRAIL acute myeloid leukemia cells to the pro-apoptotic effects of hypoxia |
| Q28211131 | Activation of the caspase-8/Bid and Bax pathways in aspirin-induced apoptosis in gastric cancer |
| Q40084690 | BRCA1 accumulates in the nucleus in response to hypoxia and TRAIL and enhances TRAIL-induced apoptosis in breast cancer cells |
| Q33420106 | Circulating cell death products predict clinical outcome of colorectal cancer patients |
| Q37761322 | Combining naturally occurring polyphenols with TNF-related apoptosis-inducing ligand: a promising approach to kill resistant cancer cells? |
| Q42009519 | Controlling TRAIL-mediated caspase-3 activation. |
| Q36177149 | Differential effects of hypoxia on etoposide-induced apoptosis according to the cancer cell lines |
| Q42906415 | Eicosapentaenoic acid restores diabetic tubular injury through regulating oxidative stress and mitochondrial apoptosis |
| Q51726366 | Expression of oxidored nitro domain-containing protein 1(NOR1) impairs nasopharyngeal carcinoma cells adaptation to hypoxia and inhibits PDK1 expression. |
| Q40202626 | Hypoxia inhibits TRAIL-induced tumor cell apoptosis: involvement of lysosomal cathepsins |
| Q37520269 | Hypoxia regulates TRAIL sensitivity of colorectal cancer cells through mitochondrial autophagy |
| Q35880778 | Hypoxia-induced autophagy mediates cisplatin resistance in lung cancer cells |
| Q35741681 | Induction of cellular prion protein (PrPc) under hypoxia inhibits apoptosis caused by TRAIL treatment |
| Q39095766 | MADD is a downstream target of PTEN in triggering apoptosis |
| Q34072314 | Overcoming hypoxic-resistance of tumor cells to TRAIL-induced apoptosis through melatonin |
| Q57243526 | Role of hypoxia inducible factor-1 alpha in modulation of apoptosis resistance |
| Q37785559 | TRAIL receptor signaling and therapeutics. |
| Q38720624 | The Effects of Hypoxia on U937 Cell Line in Mesenchymal Stem Cells Co-Culture System |
| Q36568989 | The potential of the tumor microenvironment to influence Apo2L/TRAIL induced apoptosis |
| Q37302737 | The promise of cancer therapeutics targeting the TNF-related apoptosis-inducing ligand and TRAIL receptor pathway |
| Q35013059 | miR-145 induces caspase-dependent and -independent cell death in urothelial cancer cell lines with targeting of an expression signature present in Ta bladder tumors |